Pancreas transplantation offers hope for people with type 1 diabetes, a disorder that causes the pancreas to stop producing enough insulin. There is evidence that transplantation can halt the progression of, and in some instances, prevent the onset of certain long-term diabetic complications.
Why choose Ohio State?Expertise:
Since our first kidney-pancreas transplant in 1985, we have performed more than 800 kidney-pancreas transplant surgeries. In addition, we have performed more than 130 pancreas transplants alone. We are also among the busiest kidney-pancreas centers in the world and the only adult transplant center in central Ohio.
Our Comprehensive Transplant Center has one of the largest organ transplant programs in the nation. We perform nearly 250 kidney, liver, pancreas, combined kidney-pancreas, heart, lung and bone marrow transplants each year. Since our program started in 1967, we have performed more than 7,700 lifesaving transplants.
We are one of the few sites in North America approved to process pancreatic islet cells for transplantation that may cure type 1 diabetes.
We participate in clinical trials of new immunosuppressive drugs and antirejection therapies. Our current standard of care is using prednisone-free immunosuppressive medications, a regimen available to about one quarter of all patients in the United States at this time.